Search earnings tickers

BMY

2025Q3BMO

Bristol-Myers Squibb Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2025-10-30 · Fiscal end 2025-09-30 · Features as of 2025-10-29

← Earnings history

Street

Consensus EPS1.52

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.1%

IV front—

P/C full—

P/C front—

Features as of2025-10-29

Run-up

Close—

Ret 5d-4.0%

Ret 10d-2.3%

Ret 20d-10.2%

Ret 30d-7.7%

Print

Actual EPS

1.63Beat

Estimated EPS1.52

Actual revenue

12.2B

Surprise %+7.2%

Beat / missBeat

Beat streak 44

Beat streak 86

Reaction

1-day stock reaction+5.4%

Implied vs actual

Implied 2.1%Actual 1.6%

Gap reaction+1.6%

Day result+7.1%

Next-day upYes

Realized / IV0.75×

Post tape

Post 5d+2.2%

Post 10d+6.6%

Post volume41.9M

Vol ×10d2.79×

Vol ×20d2.70×

Post range6.1%

BMY

Pre-Earnings Data